ADGRL2
Basic information
Region (hg38): 1:81306147-81993932
Previous symbols: [ "LPHH1", "LPHN2" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ADGRL2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 13 | 17 | ||||
missense | 58 | 71 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 2 | 2 | ||||
non coding | 1 | |||||
Total | 0 | 0 | 58 | 19 | 12 |
Variants in ADGRL2
This is a list of pathogenic ClinVar variants found in the ADGRL2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-81836976-G-A | ADGRL2-related disorder | Likely benign (Apr 02, 2019) | ||
1-81836992-C-T | not specified | Uncertain significance (Jul 19, 2023) | ||
1-81837010-G-A | Likely benign (Aug 01, 2022) | |||
1-81837028-T-C | not specified | Uncertain significance (Sep 20, 2023) | ||
1-81907037-C-G | not specified | Uncertain significance (Jun 24, 2022) | ||
1-81907066-C-T | Likely benign (Feb 01, 2023) | |||
1-81907088-C-G | not specified | Uncertain significance (Dec 16, 2022) | ||
1-81907118-A-G | not specified | Uncertain significance (Aug 26, 2022) | ||
1-81936728-G-T | not specified | Uncertain significance (Jun 24, 2022) | ||
1-81936761-T-A | ADGRL2-related disorder | Likely benign (May 24, 2019) | ||
1-81943130-G-T | not specified | Uncertain significance (Nov 17, 2022) | ||
1-81943172-T-C | not specified | Uncertain significance (Jul 12, 2022) | ||
1-81943464-T-A | not specified | Uncertain significance (Aug 08, 2023) | ||
1-81943585-C-T | ADGRL2-related disorder | Likely benign (Aug 01, 2022) | ||
1-81943664-A-G | not specified | Uncertain significance (Nov 20, 2023) | ||
1-81943716-A-G | not specified | Uncertain significance (Jun 29, 2023) | ||
1-81943736-T-C | not specified | Uncertain significance (Jul 15, 2021) | ||
1-81943763-G-A | not specified | Uncertain significance (Jun 07, 2023) | ||
1-81950227-C-G | not specified | Uncertain significance (Feb 07, 2023) | ||
1-81950239-A-G | not specified | Uncertain significance (Apr 01, 2024) | ||
1-81950246-C-T | not specified | Uncertain significance (Feb 06, 2023) | ||
1-81950260-A-G | not specified | Uncertain significance (May 30, 2024) | ||
1-81950266-C-G | not specified | Uncertain significance (Nov 01, 2022) | ||
1-81950298-A-T | ADGRL2-related disorder | Benign (May 13, 2019) | ||
1-81950339-T-C | not specified | Uncertain significance (Feb 14, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ADGRL2 | protein_coding | protein_coding | ENST00000319517 | 19 | 686276 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 1.88e-9 | 125728 | 0 | 17 | 125745 | 0.0000676 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.22 | 647 | 741 | 0.873 | 0.0000383 | 9215 |
Missense in Polyphen | 261 | 349.46 | 0.74686 | 4363 | ||
Synonymous | -0.552 | 282 | 270 | 1.04 | 0.0000149 | 2692 |
Loss of Function | 7.33 | 3 | 68.5 | 0.0438 | 0.00000420 | 775 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000127 | 0.000127 |
Ashkenazi Jewish | 0.0000994 | 0.0000992 |
East Asian | 0.0000556 | 0.0000544 |
Finnish | 0.0000927 | 0.0000924 |
European (Non-Finnish) | 0.0000627 | 0.0000615 |
Middle Eastern | 0.0000556 | 0.0000544 |
South Asian | 0.0000399 | 0.0000327 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Calcium-independent receptor of low affinity for alpha- latrotoxin, an excitatory neurotoxin present in black widow spider venom which triggers massive exocytosis from neurons and neuroendocrine cells. Receptor probably implicated in the regulation of exocytosis. {ECO:0000250|UniProtKB:O88923}.;
- Pathway
- GPCRs, Other;GPCRs, Class B Secretin-like
(Consensus)
Recessive Scores
- pRec
- 0.262
Intolerance Scores
- loftool
- rvis_EVS
- -0.19
- rvis_percentile_EVS
- 39.31
Haploinsufficiency Scores
- pHI
- 0.906
- hipred
- Y
- hipred_score
- 0.609
- ghis
- 0.535
Essentials
- essential_gene_CRISPR
- essential_gene_CRISPR2
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- gene_indispensability_score
Mouse Genome Informatics
- Gene name
- Adgrl2
- Phenotype
- behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Gene ontology
- Biological process
- cell surface receptor signaling pathway;G protein-coupled receptor signaling pathway;adenylate cyclase-activating G protein-coupled receptor signaling pathway;brain development
- Cellular component
- integral component of plasma membrane;integral component of membrane;neuron projection
- Molecular function
- G protein-coupled receptor activity;latrotoxin receptor activity;carbohydrate binding